247 related articles for article (PubMed ID: 9407954)
21. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
22. Adenomatous polyposis coli I1307K mutation in Jewish patients with different ethnicity: prevalence and phenotype.
Drucker L; Shpilberg O; Neumann A; Shapira J; Stackievicz R; Beyth Y; Yarkoni S
Cancer; 2000 Feb; 88(4):755-60. PubMed ID: 10679643
[TBL] [Abstract][Full Text] [Related]
23. BRCA germline mutations in Jewish women with uterine serous papillary carcinoma.
Lavie O; Hornreich G; Ben-Arie A; Rennert G; Cohen Y; Keidar R; Sagi S; Lahad EL; Auslander R; Beller U
Gynecol Oncol; 2004 Feb; 92(2):521-4. PubMed ID: 14766242
[TBL] [Abstract][Full Text] [Related]
24. The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Satagopan JM; Offit K; Foulkes W; Robson ME; Wacholder S; Eng CM; Karp SE; Begg CB
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):467-73. PubMed ID: 11352856
[TBL] [Abstract][Full Text] [Related]
25. The I1307K APC polymorphism: prevalence in non-Ashkenazi Jews and evidence for a founder effect.
Shtoyerman-Chen R; Friedman E; Figer A; Carmel M; Patael Y; Rath P; Fidder HH; Bar-Meir S; Theodor L
Genet Test; 2001; 5(2):141-6. PubMed ID: 11551102
[TBL] [Abstract][Full Text] [Related]
26. Coinheritance of BRCA1 and BRCA2 mutations with Fanconi anemia and Bloom syndrome mutations in Ashkenazi Jewish population: possible role in risk modification for cancer development.
Koren-Michowitz M; Friedman E; Gershoni-Baruch R; Brok-Simoni F; Patael Y; Rechavi G; Amariglio N
Am J Hematol; 2005 Mar; 78(3):203-6. PubMed ID: 15726604
[TBL] [Abstract][Full Text] [Related]
27. Germline CHEK2 mutations in Jewish Ashkenazi women at high risk for breast cancer.
Laitman Y; Kaufman B; Lahad EL; Papa MZ; Friedman E
Isr Med Assoc J; 2007 Nov; 9(11):791-6. PubMed ID: 18085035
[TBL] [Abstract][Full Text] [Related]
28. The effect of the I1307K APC polymorphism on the clinicopathological features and natural history of breast cancer.
Yuan ZQ; Bégin LR; Wong N; Brunet JS; Trifiro M; Gordon PH; Pinsky L; Foulkes WD
Br J Cancer; 1999 Nov; 81(5):850-4. PubMed ID: 10555757
[TBL] [Abstract][Full Text] [Related]
29. The APCI1307K allele and cancer risk in a community-based study of Ashkenazi Jews.
Woodage T; King SM; Wacholder S; Hartge P; Struewing JP; McAdams M; Laken SJ; Tucker MA; Brody LC
Nat Genet; 1998 Sep; 20(1):62-5. PubMed ID: 9731533
[TBL] [Abstract][Full Text] [Related]
30. Common origin of the I1307K APC polymorphism in Ashkenazi and non-Ashkenazi Jews.
Patael Y; Figer A; Gershoni-Baruch R; Papa MZ; Risel S; Shtoyerman-Chen R; Karasik A; Theodor L; Friedman E
Eur J Hum Genet; 1999 Jul; 7(5):555-9. PubMed ID: 10439961
[TBL] [Abstract][Full Text] [Related]
31. High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer.
Grzybowska E; Zientek H; Jasinska A; Rusin M; Kozlowski P; Sobczak K; Sikorska A; Kwiatkowska E; Gorniak L; Kalinowska E; Utracka-Hutka B; Wloch J; Chmielik E; Krzyzosiak WJ
Hum Mutat; 2000 Dec; 16(6):482-90. PubMed ID: 11102977
[TBL] [Abstract][Full Text] [Related]
32. The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel.
Vazina A; Baniel J; Yaacobi Y; Shtriker A; Engelstein D; Leibovitz I; Zehavi M; Sidi AA; Ramon Y; Tischler T; Livne PM; Friedman E
Br J Cancer; 2000 Aug; 83(4):463-6. PubMed ID: 10945492
[TBL] [Abstract][Full Text] [Related]
33. Concomitant BRCA1 and BRCA2 gene mutations in an Ashkenazi Jewish woman with primary breast and ovarian cancer.
Spannuth WA; Thaker PH; Sood AK
Am J Obstet Gynecol; 2007 Apr; 196(4):e6-9. PubMed ID: 17403394
[TBL] [Abstract][Full Text] [Related]
34. The I1307K adenomatous polyposis coli gene variant does not contribute in the assessment of the risk for colorectal cancer in Ashkenazi Jews.
Strul H; Barenboim E; Leshno M; Gartner M; Kariv R; Aljadeff E; Aljadeff Y; Kazanov D; Strier L; Keidar A; Knaani Y; Degani Y; Alon-Baron L; Sobol-Dvory H; Halpern Z; Arber N
Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1012-5. PubMed ID: 14578136
[TBL] [Abstract][Full Text] [Related]
35. Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.
Kauff ND; Mitra N; Robson ME; Hurley KE; Chuai S; Goldfrank D; Wadsworth E; Lee J; Cigler T; Borgen PI; Norton L; Barakat RR; Offit K
J Natl Cancer Inst; 2005 Sep; 97(18):1382-4. PubMed ID: 16174860
[TBL] [Abstract][Full Text] [Related]
36. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
37. The APC p.I1307K polymorphism is a significant risk factor for CRC in average risk Ashkenazi Jews.
Boursi B; Sella T; Liberman E; Shapira S; David M; Kazanov D; Arber N; Kraus S
Eur J Cancer; 2013 Nov; 49(17):3680-5. PubMed ID: 23896379
[TBL] [Abstract][Full Text] [Related]
38. The characterization of somatic APC mutations in colonic adenomas and carcinomas in Ashkenazi Jews with the APC I1307K variant using linkage disequilibrium.
Zauber NP; Sabbath-Solitare M; Marotta SP; Bishop DT
J Pathol; 2003 Feb; 199(2):146-51. PubMed ID: 12533826
[TBL] [Abstract][Full Text] [Related]
39. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
[TBL] [Abstract][Full Text] [Related]
40. Analysis of breast cancer susceptibility genes BRCA1 and BRCA2 in Thai familial and isolated early-onset breast and ovarian cancer.
Patmasiriwat P; Bhothisuwan K; Sinilnikova OM; Chopin S; Methakijvaroon S; Badzioch M; Padungsutt P; Vattanaviboon P; Vattanasapt V; Szabo C; Saunders GF; Goldgar D; Lenoir GM
Hum Mutat; 2002 Sep; 20(3):230. PubMed ID: 12203997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
